Search

everythinglearnresearchcommunity

for

Search:↓

The survey helps identify menstrual irregularities and excess male hormones, aiming to detect conditions like Polycystic Ovary Syndrome.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Finasteride exposure harms tadpole reproduction and hormone balance.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Neuroimaging suggests that treatments targeting brain steroids could help control epilepsy, especially types linked to the menstrual cycle.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Multimedia education greatly improves women's knowledge and management of PCOS.

Lifestyle changes and medication can improve the quality of life for women with PCOS by reducing complications.

High testosterone increases heart disease risk in women with PCOS.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.